Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays.

Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays.

Finding new peptide biomarkers for stomach cancer in human sera that can be implemented into a clinically practicable prediction method for monitoring of stomach cancer. We studied the serum peptidome from two different biorepositories. We first employed a C8-reverse phase liquid chromatography appr...

Full description

Bibliographic Details
Main Authors: Meital Cohen, Rami Yossef, Tamir Erez, Aleksandra Kugel, Michael Welt, Mark M Karpasas, Jonathan Bones, Pauline M Rudd, Julien Taieb, Herve Boissin, Dror Harats, Karin Noy, Yoram Tekoah, Rachel G Lichtenstein, Eitan Rubin, Angel Porgador
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3022591?pdf=render

Internet

http://europepmc.org/articles/PMC3022591?pdf=render

Similar Items